A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
The Scientist
Most Recent
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.
A public interest legal group has renewed the fight against DNA patenting.
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
Page 1 of 1
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
